Compounded Tirzepatide (GLP-1/GIP) is a once-weekly injectable therapy that mimics dual incretin hormones, potentially offering stronger support for appetite regulation and metabolic balance than GLP-1 alone.
In-Stock
RoenRx does not manufacture compounded medications. Actual product appearance and labeling of the medication you receive will differ from website images.
$354
A next-generation Compounded Tirzepatide (GLP-1/GIP) injection, combining dual pathways for appetite regulation and metabolic improvement, designed to support significant progress in weight care and health goals.
1 Month Supply
Compounded Tirzepatide (GLP-1/GIP) is a once-weekly injectable therapy that mimics dual incretin hormones, potentially offering stronger support for appetite regulation and metabolic balance than GLP-1 alone.
This dual-acting option combines two pathways in one medication, giving patients a next-generation therapy under professional guidance in a convenient, accessible setting.
RoenRx’s weight loss program provides access to compounded medications therapies with licensed clinician oversight. Care is paired with transparent pricing, telehealth convenience, and ongoing support—helping you explore safe, science-driven options for reaching your health goals in a way that fits your lifestyle.
© 2026 Roen, Inc. All rights reserved.
30 Irving Pl, New York, NY 10003
877-870-0323
The assessment available on the RoenRx website does not create a doctor–patient relationship. Clinical services are provided by OpenLoop Health and other networks of U.S.-licensed clinicians who determine eligibility for GLP-1 treatment based on medical history and assessment responses. Providers retain full discretion to prescribe or decline compounded GLP-1 medications. Compounded medications offered through RoenRx are produced in FDA-registered facilities but are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality. Results may vary and depend on individual adherence, provider guidance, and lifestyle changes. RoenRx does not manufacture compounded medications, and product appearance may differ from website images. RoenRx partners with certified U.S. pharmacies to ensure high standards of safety and quality. Medication costs are included in the RoenRx program. Zepbound® is FDA-approved for chronic weight management; Ozempic® is FDA-approved for type 2 diabetes treatment but may be prescribed off-label for weight management. All trademarks are the property of their respective owners. Unless otherwise noted, results reflect RoenRx patient experiences rather than public clinical studies.
*Our success rate reflects recent internal fulfillment and delivery performance for paid orders during the current quarter. Rates may vary based on pharmacy capacity, state regulations, and individual order details. This figure does not represent clinical outcomes or individual results and is subject to change as new data becomes available. Written prescription or weight loss results are not guaranteed.
By using our services, you agree to our Terms & Conditions. For information on refunds, please visit our Refund Policy.
Spring Sale Ends 4/24!